Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

22.23
-0.5650-2.48%
Volume:77.87K
Turnover:1.74M
Market Cap:2.66B
PE:-10.37
High:22.62
Open:22.44
Low:22.10
Close:22.79
52wk High:42.21
52wk Low:22.10
Shares:119.54M
Float Shares:92.51M
Volume Ratio:1.39
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1442
EPS(LYR):-1.7211
ROE:-36.81%
ROA:-20.11%
PB:4.21
PE(LYR):-12.91

Loading ...

NewAmsterdam Pharma to Host Investor Day Webcast for Analysts, Investors

Reuters
·
Jul 29

Truist Financial Reaffirms Their Buy Rating on NewAmsterdam Pharma Company (NAMS)

TIPRANKS
·
Jul 27

Newamsterdam Pharma Says EU CHMP Backs Approval of Ubeslo, Evlarco Cholesterol Drugs

Reuters
·
Jul 27

Newamsterdam Says EU CHMP Backs Ubeslo, Evlarco Cholesterol Drugs for Approval

Reuters
·
Jul 26

Analysts’ Top Healthcare Picks: NewAmsterdam Pharma Company (NAMS), Zevra Therapeutics (ZVRA)

TIPRANKS
·
Jul 25

Newamsterdam Pharma Says EMA Panel Backs EU Approval for Ubeslo, Evlarco Cholesterol Drugs

Reuters
·
Jul 24

Newamsterdam Pharma COO Douglas Kling Resigns, Effective Aug. 14

Reuters
·
Jul 23

Newamsterdam Pharma Chief Accounting Officer Louise Kooij Disposes of Ordinary Shares Worth $3.08 Million

Reuters
·
Jul 23

Newamsterdam Pharma Publishes Obicetrapib Alzheimer’s Prevention Research Presentation

Reuters
·
Jul 17

Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar

Simply Wall St.
·
Jul 12

Did NewAmsterdam’s (NAMS) Alzheimer’s Biomarker Signal Just Recast Obicetrapib’s Dual-Disease Investment Narrative?

Simply Wall St.
·
Jul 09

Newamsterdam Pharma Grants 28,700 Inducement Share Options Priced at $35.17

Reuters
·
Jul 03

Newamsterdam Pharma to Present Obicetrapib Data for Early Alzheimer’s Prevention at AAIC 2026

Reuters
·
Jul 01

NewAmsterdam Pharma's Obicetrapib Could Capture Market Share, RBC Capital Markets Says

MT Newswires Live
·
Jun 30

RBC Raises Price Target on NewAmsterdam Pharma to $51 From $47, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Jun 30

Newamsterdam Pharma Chief Accounting Officer Louise Kooij Sells USD 1.21 Million in Shares

Reuters
·
Jun 25

NewAmsterdam Pharma posts real-world study presentation on high-intensity statin intolerance, adverse events

Reuters
·
Jun 17

Did Druckenmiller’s Spotlight and ESOP Shelf Just Reframe NewAmsterdam Pharma’s (NAMS) Obicetrapib Story?

Simply Wall St.
·
Jun 09

NewAmsterdam Pharma to present obicetrapib data at National Lipid Association Scientific Sessions

Reuters
·
Jun 03

NewAmsterdam Pharma shareholders approve 2026 employee stock purchase plan at annual meeting

Reuters
·
Jun 03